1. Home
  2. CASS vs ALLO Comparison

CASS vs ALLO Comparison

Compare CASS & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

HOLD

Current Price

$55.33

Market Cap

714.9M

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

597.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASS
ALLO
Founded
1906
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
597.7M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
CASS
ALLO
Price
$55.33
$1.79
Analyst Decision
Buy
Strong Buy
Analyst Count
1
15
Target Price
$45.00
$8.35
AVG Volume (30 Days)
65.9K
5.0M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
34.09
EPS
1.48
N/A
Revenue
$190,750,000.00
N/A
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
$142,416.42
P/E Ratio
$37.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$1.04
52 Week High
$59.63
$4.46

Technical Indicators

Market Signals
Indicator
CASS
ALLO
Relative Strength Index (RSI) 39.05 37.24
Support Level $51.22 $1.59
Resistance Level $59.63 $1.92
Average True Range (ATR) 1.39 0.11
MACD -0.37 -0.04
Stochastic Oscillator 0.00 12.62

Price Performance

Historical Comparison
CASS
ALLO

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

Share on Social Networks: